Board Members

Jan Hellqvist

Chairman of the board Jan Hellqvist has over 30 years’ extensive experience in the life science industry with a special focus on restructuring and growing companies to produce strong growth and profit. He has held senior executive and management roles in the pharma service industry, including medical devices, diagnostics and Contract Research, and has extensive experience in the Respiratory sector, including senior roles at Astra and Astra Zeneca on their blockbuster asthma treatments Pulmicort®, and Symbicort®. He has held senior positions in sales, business development, global marketing and executive international management at companies including AstraZeneca, Stryker, Dako, TFS & LINK Medical, KLIFO and others. Mr. Hellqvist has an EMBA (Executive Master of Business Administration) from Lund University.

Per Gerde

Associate Professor of Inhalation Toxicology, Scientist at the Division of Physiology, Institute of Environmental Medicine at the Karolinska Institutet. Previous appointments include scientist at the Lovelace Respiratory Research Institute (1993– 1998), scientist at the Swedish National Institute of Occupational Health (1991–1996), and postdoctoral fellow at the Lovelace Respiratory Research Institute (1989–1991). Dr. Gerde has published approx. 30 peer reviewed scientific papers. He is also the main inventor of six patent families with related patent applications.

Niklas Lindecrantz

Niklas has a Master of Science in Finance from Stockholm University and has experience from leading positions in several companies as CFO and Finance Manager. Niklas is currently CFO of Chordate Medical AB, Chairman of the Board of Lati2d Consulting AB, member of L-z Consulting AB and Lzinvest AB.

Ulf Ericsson

Ulf Ericsson has over 25 years of experience in Life Science, specializing in pharmaceuticals, inhaler devices, and inhalation formulations with a special focus on Strategic Marketing and Business Development, and experience in all stages of the product life cycle from pre-clinical, new product planning, pre-launch, launch and life cycle management. For over twenty years, Ulf has worked in the field of inhalation, of which 17 years in AstraZeneca in senior positions with global responsibility. Ulf have also held senior positions in other global companies like Takeda. Ulf has a Master of Science in Business Administration from Lund University.